Drug
Antithrombin III clinical trials
Also written Thrombate III and Atenativ.
Includes 1 study of Antithrombin-III.
- studies test it
- 12
- open now
- 1
- in phase 3
- 2
- first study started
- 2009
Keep track of what changes. Save the Antithrombin III studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Brand
Other names
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2011 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 5
- Phase 3
- 2
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 9
Universitaire Ziekenhuizen KU Leuven (1) · Seoul National University Hospital (1) · Duke University (1) · Grifols Therapeutics LLC (1) · Children's Hospital Medical Center, Cincinnati (1) · Instituto Grifols, S.A. (1) · The Hospital for Sick Children (1) · Octapharma (1)
Often tested with
Tested in the same studies.
Infliximab (1) · Apotransferrin (1) · Complement C1 Inhibitor Protein (1) · Glutathione (1) · Melatonin (1) · Epoprostenol (1) · Continuous Infusion Procedure (1)
Studies
Open first, then newest update. How each study uses Antithrombin III is read from its arms, and is right about nine times in ten.
Testing it · 12
- Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or DeliveryRecruitingPhase 3OctapharmaNCT04918173Written as Atenativ
- Combined Drug Approach to Prevent Ischemia-reperfusion Injury During Transplantation of Livers (CAPITL)CompletedPhase 2Universitaire Ziekenhuizen KU LeuvenNCT02251041Written as Antithrombin-III
- Antithrombin III in Infectious Disease Caused by COVID-19TerminatedPhase 2Enrique GinzburgNCT04899232Written as Antithrombin III
- Antithrombin III Concentrate After Liver TransplantationCompletedNot applicableSeoul National University HospitalNCT04219579Written as Antithrombin III, continuous infusion
- Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With CirrhosisWithdrawnPhase 1Jonathan StineNCT04055389Written as Antithrombin III
- Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac SurgeryCompletedPhase 2Duke UniversityNCT02103114Written as Anti-thrombin III
- Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary BypassCompletedPhase 2Grifols Therapeutics LLCNCT02037555Written as AT-III (Human)
- Evaluation Of The Pharmacokinetics Of Antithrombin III In Neonates And Infants Undergoing CPB And ECMO SupportCompletedPhase 1Children's Hospital Medical Center, CincinnatiNCT02631174Written as Antithrombin III
- Atenativ Effect on Uterine Blood Flow and PreeclampsiaWithdrawnPhase 4Vastra Gotaland RegionNCT02278575Written as Atenativ
- Use of Antithrombin in Cardiac Surgery With Cardiopulmonary BypassCompletedPhase 2Instituto Grifols, S.A.NCT00823082Written as Antithrombin III
- Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac SurgeryCompletedPhase 3The Hospital for Sick ChildrenNCT01530737Written as Antithrombin III
- Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac SurgeryStatus unknownPhase 4University of BariNCT01201070Written as antithrombin III
Codes
What other systems call Antithrombin III · ClinicalTrials.gg INT007011
- MeSH (NLM) D000990Antithrombin IIIOne source ClinicalTrials.gov
- UNII (FDA) T0LTO7L82XANTITHROMBIN III HUMANOne source FDA
- RxNorm 221062One source FDA
- NCI Thesaurus C136824Therapeutic Human Antithrombin-IIIOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000990 | Antithrombin III | One source ClinicalTrials.gov |
| UNII (FDA) | T0LTO7L82X | ANTITHROMBIN III HUMAN | One source FDA |
| RxNorm | 221062 | — | One source FDA |
| NCI Thesaurus | C136824 | Therapeutic Human Antithrombin-III | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.